Pacira BioSciences, Inc. (PCRX) ownership: insiders 4% · institutions 100% · index and ETF funds 16% (13F 2026-03-31). Insider activity, 90 days: Routine (1 sales, 0 open-market buys). 10 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 6735343.00 | $152.22M | 16.9% | 2026-03-31 |
| Vanguard | 4674255.00 | $105.64M | 11.7% | 2026-03-31 |
| Doma Perpetual Capital Management LLC | 2777794.00 | $62.78M | 7.0% | 2026-03-31 |
| Dimensional Fund Advisors | 2060597.00 | $46.57M | 5.2% | 2026-03-31 |
| D. E. Shaw | 1982724.00 | $44.81M | 5.0% | 2026-03-31 |
| State Street | 1919610.00 | $43.38M | 4.8% | 2026-03-31 |
| Renaissance Technologies | 1825501.00 | $41.26M | 4.6% | 2026-03-31 |
| Goldman Sachs | 1569916.00 | $35.48M | 3.9% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-04-23 | |
| Sell | null | 2026-04-23 | |
| Sell | null | 2026-04-23 | |
| Sell | null | 2026-04-22 | |
| Sell | null | 2026-04-22 | |
| Sell | null | 2026-04-22 | |
| Sell | null | 2026-04-21 |
Back to PCRX overview · PCRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.